Search | World Obesity Federation
English عربى

Search

Search

Searched for . Search results: 2070

What is driving the obesity pandemic? Ultraprocessed foods, our bodies being fooled by them, and it’s easier to gain weight than lose it

New class of GLP-1 drugs, when more widely available, could help interrupt the pandemic.

View
Accounts 2025

Annual Report and Financial Statements for the World Obesity Federation, for year ending 31 December 2025.

View
Study estimates thousands of deaths could be prevented by halving ultra-processed food consumption

New research suggests that between 23-38% of cardiovascular deaths are attributable to ultra-processed food consumption.

View
Study shows how GLP-1 obesity drugs are associated with reduced systemic inflammation beyond their anti-obesity effects

GLP-1 class of obesity drugs associated with a marked reduction in systemic inflammation beyond anti-obesity effects.

View
Annual Report 2025

Annual Review and Report for the World Obesity Federation, for the year ending 31 December 2025.

View
Study is first to show behavioural weight loss interventions reduce the risk of obesity-related cancers in people living with overweight and obesity

Behavioural weight loss interventions reduce the risk of obesity-related cancers in people living with obesity.

View
Coca-Cola’s “sportswashing” of health-harming products at World Cup & previous major sporting events including Olympic Games amplified by digital media

New research exposes new marketing tactics by Coca-Cola and calls for greater scrutiny of its health-harming activities.

View
Internet searches on weight-loss drugs have soared 25-fold in past decade

25-fold increase in internet searches for obesity medication sparks concern, study shows.

View
SCOPE School Mexico

In conjunction with ICO 2026, SCOPE School is coming to Mexico City, Mexico, this 14 July.

View
Obesity Lived Experience Global Summit 2026

At ICO 2026, this Summit will bring together people living with obesity or related conditions

View